Frequency of creatine kinase elevation during treatment with fluvastatin.
Benghozi
Renee
R
Novartis Pharma LTD, Basel, Switzerland.
Bortolini
Michele
M
Jia
Yan
Y
Isaacsohn
Jonathan L
JL
Troendle
August J
AJ
Gonasun
Leonard
L
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003402:Creatine Kinase / Q000097:blood / Q000187:drug effects*; D003692:Delayed-Action Preparations; D005229:Fatty Acids, Monounsaturated / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D000077340:Fluvastatin; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000924:Anticholesteremic Agents; D003692:Delayed-Action Preparations; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D000077340:Fluvastatin; D003402:Creatine Kinase